Medicure (TSE:MPH) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Medicure Inc. has completed the acquisition of intellectual property from CanAm Bioresearch, securing new chemical entities that could revolutionize disease treatment pending further studies and regulatory approval. The deal includes initial cash payment and milestone payments, plus a share of future net proceeds relating to the assets, indicating a strong potential for future revenue growth.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.